ODDB.org: Open Drug Database

Spirig HealthCare AG - Methylphenidat Spirig HC retard 27 mg, Retardtabletten

Swissmedic Registration	69315	Sequence	02
Product name	Methylphenidat Spirig HC retard 27 mg	Description	Retardtabletten
ATC-Classification	N06BA04	ATC-Description	Methylphenidate
Introduction of Sequence	04.01.2024

Composition

methylphenidati hydrochloridum 27 mg, hypromellosum, macrogolum 200'000, macrogolum 7'000'000, acidum succinicum, magnesii stearas, natrii chloridum corresp. natrium 9.4 mg, silica colloidalis anhydrica, E 172 (nigrum), Überzug: cellulosi acetas, hypromellosum, macrogolum 3350, lactosum monohydricum 3.4 mg, E 171, triacetinum, E 172 (nigrum), E 172 (rubrum), acidum phosphoricum, pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
Methylphenidate Hydrochloride	27 mg

BAG: Active Agent	Dose
Methylphenidate Hydrochloride	27 mg

Inactive agents	Dose	additional_information
(Nigrum)
(Rubrum)
Phosphoric Acid
Succinic Acid
Cellulosi Acetas		Überzug
E 171		color.
E 172		color.
Hypromellosum
Lactose Monohydrate	3.4 mg
Macrogol	3350
Magnesii Stearas
Sodium Chloride
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Triacetinum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	30	25.70	44.35	A+	SL	No
004	60	45.23	65.60	A+	SL	No

2026	©ywesee GmbH